Related Experiment Video
Updated: Feb 4, 2026
06:06
Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
3.1K
Exenatide implant therapy in diabetes
1Department of Endocrinology, Bharti Hospital, Karnal,India.
JPMA. the Journal of the Pakistan Medical Association
|October 15, 2018
Summary
ITCA 650 offers a novel approach to type 2 diabetes management by providing continuous subcutaneous delivery of exenatide, a glucagon-like peptide 1 receptor agonist. This implantable device ensures stable drug concentrations, potentially improving therapeutic outcomes.
Area of Science:
- Endocrinology and Metabolism
- Pharmacology and Pharmaceutical Sciences
- Biomedical Engineering and Drug Delivery Systems
Background:
- Type 2 diabetes mellitus (T2DM) management requires effective pharmacotherapeutics and drug delivery systems.
- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are crucial for T2DM treatment, but often require frequent injections.
- Challenges in adherence and stable drug concentrations can limit the efficacy of traditional GLP-1 RA delivery methods.
Purpose of the Study:
- To review the ITCA 650, an innovative implantable device for sustained exenatide delivery.
- To discuss the pharmacodynamics and pharmacokinetics of exenatide delivered via ITCA 650.
- To explore the clinical utility, advantages, limitations, and rational use of ITCA 650 in T2DM care.
Main Methods:
- Review of existing literature and clinical data on ITCA 650.
- Analysis of pharmacodynamic and pharmacokinetic profiles of exenatide from the device.
- Discussion of clinical implications and practical considerations for healthcare providers.
Main Results:
- ITCA 650 provides stable and sustained subcutaneous delivery of exenatide, a GLP-1 RA.
- The device demonstrates predictable pharmacokinetics and pharmacodynamics, potentially enhancing glycemic control.
- Advantages include improved adherence and consistent drug exposure compared to daily/weekly injections.
Conclusions:
- ITCA 650 represents a significant advancement in diabetes pharmacotherapeutics and drug delivery for T2DM.
- The device offers a promising option for optimizing exenatide therapy, addressing limitations of conventional administration.
- Rational use of ITCA 650 can improve patient outcomes and clinical management of type 2 diabetes.
Related Concept Videos
01:20Pathophysiology of Diabetes
3.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
00:59Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
01:15Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
01:19Psychoneuroimmunology: Diabetes and Cancer
500
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
500
01:26Group Therapy
439
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
439
01:22Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K